Keep up with the latest trends and applications of AI in healthcare from the experts at AllazoHealth. Find best practices, tools, and breakthroughs in using artificial intelligence to drive meaningful engagement and outcomes for patient support programs and pharmaceutical marketing.
Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer medications (OAMs). There…
Read more
AllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation. Barriers to therapy initiation…
Read more
This year’s election could have a major effect on adherence rates. Here are some possible changes in healthcare policy that could be enacted under Trump or Biden, and the impact on adherence. Revocation of the…
Read more
Polypharmacy, the simultaneous use of multiple drugs, is becoming more common as the population ages. More than 30% of older adults in the United States take five or more drugs, typically for multiple chronic conditions.…
Read more
Are you responsible for improving your plan’s quality ratings? Learn how to improve your performance on Star and other quality measures. Download our deck and get specific advice for payers on: The influence of population…
Read more
Payers, pharmacies and pharmaceutical companies are starting to join providers in recognizing that social determinants of health (SDOH) have a major impact on patient adherence and clinical outcomes. Healthcare organizations now face the challenge of…
Read more
With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers. According to Andrea Kasprzyk, Director of Sales at…
Read more
Besides being a financial issue for pharmaceutical companies, unfilled prescriptions can lead to poorer health outcomes, drive up overall cost of care, and can have an impact on provider performance under value-based payment models. Pharmaceutical…
Read more
Partnering with Blue Cross Blue Shield of North Carolina on a randomized control trial, AllazoHealth demonstrated a 5.5 times uplift in adherence compared with traditional programs. In addition, the study showed our artificial intelligence (AI)…
Read more
What do payers consider as they grapple with the medication access and adherence needs of at-risk patients during the Covid-19 pandemic? Experts at McMann Managed Markets and Syneos Health surveyed their proprietary payer advisory boards…
Read more